Amazon's new ad-free streaming upgrade comes with a lot of perks for subscribers, but most of the important ones were included at no additional cost in the company's previous arrangement. Fans have ...

Bullseye American Ingenuity Fund portfolio manager Adam Johnson Adam Johnson clarifies that current market volatility stems from algorithms reacting to headlines. Bullseye American Ingenuity Fund ...

Treasury CS John Mbadi has arrived at the Parliament Buildings in Nairobi to present the 2026/27 budget, valued at Sh4.84 trillion. The CS left the Treasury building around 2 pm, briefly stopping for ...

Adam Mosseri wants AI to give users a sense of control over recommendations. Adam Mosseri wants AI to give users a sense of control over recommendations. is a senior reporter covering technology, ...

In an era dominated by social media, misinformation has become an all too familiar foe, infiltrating our feeds and sowing seeds of doubt and confusion. With more than half of social media users across ...

YouTube has officially altered the outlook for digital video creators and viewers by transitioning from a voluntary AI disclosure policy to a mandatory, automated detection system. Under the ...

Evan is a Communications student based in Edmonton, Alberta. Formerly a sports writer, he was drawn to Game Rant by his longtime passion for video games. An avid gamer since the age of 13, Evan has ...

It’s hard to ignore the seismic shifts brought about by algorithm-driven content. Every time you scroll through your social media feed or check your favorite news app, algorithms are diligently at ...

Hyundai officially unveiled the IONIQ 3 at Milan Design Week last Monday, a smaller, more affordable sibling to the IONIQ 5. It’s the first compact EV under Hyundai’s IONIQ lineup. Although it bears ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...

Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) – the first and only cleared for ...